Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Oct 15;28(1):335.
doi: 10.1186/s13054-024-05119-3.

Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 study

Fabio Silvio Taccone  1   2   3 , Alain Cariou  4   5   6 , Stefano Zorzi  7   6 , Hans Friberg  8   9   6 , Janus C Jakobsen  10   11   6 , Per Nordberg  12   6 , Chiara Robba  13   6 , Jan Belohlavek  6   14   15 , Jan Hovdenes  6   16 , Matthias Haenggi  6   17 , Anders Åneman  6   18 , Anders Grejs  6   19 , Thomas R Keeble  6   20   21 , Filippo Annoni  7   4   6 , Paul J Young  6   22   23   24   25 , Matt P Wise  6   26 , Tobias Cronberg  6   27 , Gisela Lilja  6   28 , Niklas Nielsen  6   28 , Josef Dankiewicz  6   29
Affiliations
Randomized Controlled Trial

Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 study

Fabio Silvio Taccone et al. Crit Care. .

Abstract

Background: The aim of this study was to assess whether hypothermia increased survival and improved functional outcome when compared with normothermia in out-of-hospital cardiac arrest (OHCA) patients with similar characteristics than in previous randomized studies showing benefits for hypothermia.

Methods: Post hoc analysis of a pragmatic, multicenter, randomized clinical trial (TTM-2, NCT02908308). In this analysis, the subset of patients included in the trial who had similar characteristics to patients included in one previous randomized trial and randomized to hypothermia at 33 °C or normothermia (i.e. target < 37.8 °C) were considered. The primary outcome was survival at 6 months; secondary outcomes included favorable functional outcome at 6 months, defined as a modified Rankin scale of 0-3. Time-to-death and the occurrence of adverse events were also reported.

Results: From a total of 1891 included in the TTM-2 study, 600 (31.7%) were included in the analysis, 294 in the hypothermia and 306 in the normothermia group. At 6 months, 207 of the 294 patients (70.4%) in the hypothermia group and 220 of the 306 patients (71.8%) in the normothermia group had survived (relative risk with hypothermia, 0.96; 95% confidence interval [CI], 0.81 to 1.15; P = 0.71). Also, 198 of the 294 (67.3%) in the hypothermia group and 202 of the 306 (66.0%) in the normothermia group had a favorable functional outcome (relative risk with hypothermia, 1.03; 95% CI, 0.87 to 1.23; P = 0.79). There was a significant increase in the occurrence of arrythmias in the hypothermia group (62/294, 21.2%) when compared to the normothermia group (43/306, 14.1%-OR 1.49, 95% CI 1.05-2.14; p = 0.026).

Conclusions: In this study, hypothermia at 33˚C did not improve survival or functional outcome in a subset of patients with similar cardiac arrest characteristics to patients in whom benefit from hypothermia was shown in prior studies.

Keywords: Cardiac arrest; Hypothermia; Outcome; Shockable rhythm.

PubMed Disclaimer

Conflict of interest statement

A Cariou, P Young, and T R Keeble reported receiving lecture fees from BD. FS Taccone received lecture fees from BD and ZOLL and is scientific advisor for Nihon Khoden, Neuroptics and Eurosets. C Robba received lectures fees from Integra, BD and Edwards. N Nielsen received lecture fees from Bard Medical and consulting fees from BrainCool. Other authors reported no potential conflict of interest relevant to this study.

Figures

Fig. 1
Fig. 1
Flow-chart of the study
Fig. 2
Fig. 2
Body temperature curves from randomization to 48 h in the hypothermia and normothermia groups for the patients in whom a core temperature was recorded. Temperature curves show the median and 95% of the observations are within the error bars
Fig. 3
Fig. 3
Probability of survival at 90 days after randomization. Kaplan–Meier estimates of the probability of survival until 90 days after randomization among patients assigned to undergo hypothermia or normothermia. Data are for the 600 patients included in the final analysis. Data were censored according to the last day of follow-up. Hazard ratio for mortality in the hypothermia group = 1.06 (95%CI 0.79–1.43)
See this image and copyright information in PMC

References

    1. Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullen S, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283–94. - DOI - PubMed
    1. Sandroni C, Nolan JP, Andersen LW, Böttiger BW, Cariou A, Cronberg T, et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults. Intensive Care Med. 2022;48(3):261–9. - DOI - PubMed
    1. Grunau B, Reynolds JC, Scheuermeyer FX, Stenstrom R, Pennington S, Cheung C, et al. Comparing the prognosis of those with initial shockable and non-shockable rhythms with increasing durations of CPR: informing minimum durations of resuscitation. Resuscitation. 2016;101:50–6. - DOI - PubMed
    1. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56. - DOI - PubMed
    1. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557–63. - DOI - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources